BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 33045417)

  • 1. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy.
    Amirdelfan K; Bae H; McJunkin T; DePalma M; Kim K; Beckworth WJ; Ghiselli G; Bainbridge JS; Dryer R; Deer TR; Brown RD
    Spine J; 2021 Feb; 21(2):212-230. PubMed ID: 33045417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study.
    Kumar H; Ha DH; Lee EJ; Park JH; Shim JH; Ahn TK; Kim KT; Ropper AE; Sohn S; Kim CH; Thakor DK; Lee SH; Han IB
    Stem Cell Res Ther; 2017 Nov; 8(1):262. PubMed ID: 29141662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total disc replacement versus multidisciplinary rehabilitation in patients with chronic low back pain and degenerative discs: 8-year follow-up of a randomized controlled multicenter trial.
    Furunes H; Storheim K; Brox JI; Johnsen LG; Skouen JS; Franssen E; Solberg TK; Sandvik L; Hellum C
    Spine J; 2017 Oct; 17(10):1480-1488. PubMed ID: 28583869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain Relief After Allogenic Stem Cell Disc Therapy.
    Lewandrowski KU; Dowling A; Vera JC; Leon JFR; Telfeian AE; Lorio MP
    Pain Physician; 2023 Mar; 26(2):197-206. PubMed ID: 36988365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up.
    Pettine K; Suzuki R; Sand T; Murphy M
    Int Orthop; 2016 Jan; 40(1):135-40. PubMed ID: 26156727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradiscal injection therapy for degenerative chronic discogenic low back pain with end plate Modic changes.
    Cao P; Jiang L; Zhuang C; Yang Y; Zhang Z; Chen W; Zheng T
    Spine J; 2011 Feb; 11(2):100-6. PubMed ID: 20850390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lumbar degenerative disc disease-associated radicular pain with culture-expanded autologous mesenchymal stem cells: a pilot study on safety and efficacy.
    Centeno C; Markle J; Dodson E; Stemper I; Williams CJ; Hyzy M; Ichim T; Freeman M
    J Transl Med; 2017 Sep; 15(1):197. PubMed ID: 28938891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, multicenter study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain.
    Khalil JG; Smuck M; Koreckij T; Keel J; Beall D; Goodman B; Kalapos P; Nguyen D; Garfin S;
    Spine J; 2019 Oct; 19(10):1620-1632. PubMed ID: 31229663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Effectiveness of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Chronic Low Back Pain Due to Severe Lumbar Spinal Degeneration: A 12-Month, Open-Label, Prospective Controlled Trial.
    Atluri S; Murphy MB; Dragella R; Herrera J; Boachie-Adjei K; Bhati S; Manocha V; Boddu N; Yerramsetty P; Syed Z; Ganjam M; Jain D; Syed Z; Grandhi N; Manchikanti L
    Pain Physician; 2022 Mar; 25(2):193-207. PubMed ID: 35322978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid- to long-term results of total lumbar disc replacement: a prospective analysis with 5- to 10-year follow-up.
    Siepe CJ; Heider F; Wiechert K; Hitzl W; Ishak B; Mayer MH
    Spine J; 2014 Aug; 14(8):1417-31. PubMed ID: 24448028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of degenerated ovine lumbar discs by STRO-3-positive allogeneic mesenchymal precursor cells combined with pentosan polysulfate.
    Oehme D; Ghosh P; Goldschlager T; Itescu S; Shimon S; Wu J; McDonald C; Troupis JM; Rosenfeld JV; Jenkin G
    J Neurosurg Spine; 2016 May; 24(5):715-26. PubMed ID: 26799116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
    Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL
    Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age on outcomes after allogeneic disc tissue supplementation in patients with chronic discogenic low back pain in the VAST trial.
    Hunter CW; Guyer R; Froimson M; DePalma MJ
    Pain Manag; 2022 Apr; 12(3):301-311. PubMed ID: 34875850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of Two Different Doses of Intradiscal Ozone-Oxygen Injection upon the Pain Alleviation in Patients with Low Back Pain: A Randomized, Single-Blind Study.
    Elawamy A; Kamel EZ; Hassanien M; Wahba OM; Amin SE
    Pain Physician; 2018 Jan; 21(1):E25-E31. PubMed ID: 29357333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Intradiscal Ozone Therapy with or without Periforaminal Steroid Injection on Lumbar Disc Herniation: A Double-Blinded Controlled Study.
    Ercalik T; Kilic M
    Pain Physician; 2020 Sep; 23(5):477-484. PubMed ID: 32967390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of disc repair with allogeneic chondrocytes presented at the 2012 Joint Spine Section Meeting.
    Coric D; Pettine K; Sumich A; Boltes MO
    J Neurosurg Spine; 2013 Jan; 18(1):85-95. PubMed ID: 23140128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, controlled trial: intradiscal electrothermal therapy versus placebo for the treatment of chronic discogenic low back pain.
    Freeman BJ; Fraser RD; Cain CM; Hall DJ; Chapple DC
    Spine (Phila Pa 1976); 2005 Nov; 30(21):2369-77; discussion 2378. PubMed ID: 16261111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion and nonsurgical treatment for symptomatic lumbar degenerative disease: a systematic review of Oswestry Disability Index and MOS Short Form-36 outcomes.
    Carreon LY; Glassman SD; Howard J
    Spine J; 2008; 8(5):747-55. PubMed ID: 18037354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Efficacy and Safety of Human Mesenchymal Stem Cell Therapy for Degenerative Disc Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Xie B; Chen S; Xu Y; Han W; Hu R; Chen M; He R; Ding S
    Stem Cells Int; 2021; 2021():9149315. PubMed ID: 34557231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intradiscal interventional therapy for degenerative chronic discogenic low back pain with end-plate Modic changes].
    Zhuang CY; Cao P; Zheng T; Yang YQ; Zhang ZW; Chen W
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2490-4. PubMed ID: 20137437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.